Concepedia

Terry Melim

TM

Statistics

Publications

6

Citations

201

H-Index

6

Active since

2005

Affiliations

AbbVie (United States)(Current)

Terry Melim is an author at AbbVie (United States) specializing in pharmacology, pharmacodynamics, and medicinal chemistry.

Publications per year

2005–2021

6

Publications

6

Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon Organoids

Sarah S. Wilson, Martha Mayo, Terry Melim et al. · Frontiers in Immunology · 2021 · 69 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors

Shiow‐Jyi Wey, Michael E. Augustyniak, Edward Cochran et al. · Journal of Medicinal Chemistry · 2007 · 55 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study

Catherine S. Tripp, Carolyn A. Cuff, Andrew Campbell et al. · Advances in Therapy · 2017 · 44 citations · Full text

Pharmacy, Immunology, Pharmacology +16

Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors

Dawn M. George, Raymond J. Huntley, Kevin P. Cusack et al. · PLoS ONE · 2018 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods

Delano V. Young, Edward Cochran, Vijay Dhawan et al. · Biochemical Pharmacology · 2005 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +8

1–5 of 6